Staggering the administration of polymyxin B and meropenem in time-kill against carbapenem-resistant Enterobacteriaceae exhibiting a wide range of meropenem MICs-Reference-Cited by-同舟云学术

Staggering the administration of polymyxin B and meropenem in time-kill against carbapenem-resistant Enterobacteriaceae exhibiting a wide range of meropenem MICs

Published:2019-03 Issue:3 Volume:93 Page:261-264
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Kulengowski Brandon,Clark Justin A.,Burgess David S.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference10 articles.

1. Methods for determining bactericidal activity of antimicrobial agents; approved guideline. CLSI document M26-A;Clinical and Laboratory Standards Institute (CLSI),1999

2. Effect of the meropenem MIC on the killing activity of meropenem and polymyxin B in combination against KPC-producing Klebsiella pneumoniae;Kulengowski;J Antibiot (Tokyo),2017

3. Effect of increasing meropenem MIC on the killing activity of meropenem in combination with amikacin or polymyxin B against MBL and KPC producing Enterobacter cloacae;Kulengowski;Diagn Microbiol Infect Dis,2018

4. Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model;Lewis;Antimicrob Agents Chemother,1998

5. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant gram-negative bacteria: an open-label, randomised controlled trial;Paul;Lancet Infect Dis,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii;Frontiers in Microbiology;2022-09-23

2. Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli;International Journal of Antimicrobial Agents;2021-05